KAWASUMI
plasmacure
evaclio
evaflux

The PlasmacureTM filters are Plasma separators. utilizing these membrane plasma separators plasma components and blood cells are separated depending on their size in plasma separation utilizing a membrane plasma separator. In this way, the plasma can be completely removed or treated. Plasma Separators can be used to separate plasma and blood cells in various plasmapheresis treatments: the Plasma Exchange (PEX) and the Double Filtration Plasmapheresis (DFPP).

The EvaclioTM filters are high cut-off filters, available in 4 models, with a different pore size distribution. Pores of all these models are significantly small in size compared to those of the conventional plasma separators. This results in smaller loss of high-molecular-weight substances such as albumin, immunoglobulins and coagulation proteins.

The EvafluxTM filters are fractionator filter. The availability of 4 different cut-offs makes possible the removing of pathogens related to their molecular weight in semi-selective way.

kawasumi
Plasmacure-PE_logo

AVAILABLE TYPES

tipologie Plasmacure

Comparison between Membrane Plasma Separation and Centrifugal Plasma Separation

No platelet contamination is observed in plasma separation utilizing membrane plasma separators, such as PLASMACURETM.

plas_h4
Evaclio

AVAILABLE TYPES

tipologie Evaclio

Features

The pores size and dimensions can help to reduce the albumin loss during PEX treatments, even if the spectrum of removed substances is limited in the low molecular weight.

Sieving Coefficent comparison

evac_h2
Evaflux

AVAILABLE TYPES

tipologie Evaflux

Protein rejection curve, in vitro tests

curve di reiezione

Double Filtration Treatments are the result of the combined use of PlasmacureTM and EvafluxTM filters.

Benefits of Double Filtration treatments:

  • Selective depletion of plasma components based on their molecular size
  • Reduced or no requirement for substitution fluid (FFP – Fresh Frozen Plasma; Albumin Sol.): lower risk of infection than in PEX treatments.
  • Treating high volumes of plasma, higher than in PEX treatments.
  • Semi-selective plasma components removal: wide range of indications, removal efficiency depending on plasma fractionators pore size.
Menu

Aferetica

Le informazioni qui pubblicate da Aferetica Srl o da terze parti sono rivolte ai professionisti sanitari. Tali informazioni non rappresentano in alcun modo la pubblicità rivolta verso il pubblico. Aferetica Srl non è responsabile dell’utilizzo di queste informazioni da parte del personale non sanitario.Proseguendo nella navigazione, l’utente dichiara di essere un professionista della sanità e di accettare i termini e le condizioni di utilizzo.

The information posted here by Aferetica Srl or any third party are dedicated to health professionals.The information posted here does not represent the advertising aimed at personnel not belonging to healthcare field.Aferetica disclaims any responsibility for the use of this website information by professionals non belonging to healthcare field. By using this website, the visitor declares to be a health professional and to accept these terms and conditions.

PROSEGUI / GO TO THE WEBSITE